Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Goodwill & Intangibles (2016 - 2025)

Historic Goodwill & Intangibles for Harvard Bioscience (HBIO) over the last 17 years, with Q3 2025 value amounting to $69.8 million.

  • Harvard Bioscience's Goodwill & Intangibles fell 4012.13% to $69.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $69.8 million, marking a year-over-year decrease of 4012.13%. This contributed to the annual value of $114.8 million for FY2024, which is 81.83% down from last year.
  • Harvard Bioscience's Goodwill & Intangibles amounted to $69.8 million in Q3 2025, which was down 4012.13% from $70.3 million recorded in Q2 2025.
  • Harvard Bioscience's 5-year Goodwill & Intangibles high stood at $124.1 million for Q2 2021, and its period low was $68.1 million during Q1 2025.
  • For the 5-year period, Harvard Bioscience's Goodwill & Intangibles averaged around $111.0 million, with its median value being $117.5 million (2022).
  • As far as peak fluctuations go, Harvard Bioscience's Goodwill & Intangibles fell by 22.13% in 2023, and later crashed by 4081.21% in 2025.
  • Quarter analysis of 5 years shows Harvard Bioscience's Goodwill & Intangibles stood at $122.6 million in 2021, then fell by 4.18% to $117.5 million in 2022, then fell by 1.48% to $115.7 million in 2023, then decreased by 0.82% to $114.8 million in 2024, then plummeted by 39.2% to $69.8 million in 2025.
  • Its last three reported values are $69.8 million in Q3 2025, $70.3 million for Q2 2025, and $68.1 million during Q1 2025.